Boryeong Pregabalin Capsule 75 mg

Adult dose

The medication is taken orally, divided into two doses per day regardless of meals. 1. Neuropathic Pain - Peripheral neuropathic pain: Initial dose of 150 mg daily, may increase to 300 mg daily after 3 to 7 days, then can be escalated to maximum of 600 mg daily at intervals of 7 days. - Central neuropathic pain: Initial dose of 150 mg daily, may increase to 300 mg daily after 1 week.

Child dose

The use of this medication is not recommended for pediatric patients under 12 years of age and adolescents aged 12 to 17 due to insufficient safety and efficacy data.

This medication may increase the risk of suicidal thoughts or behaviors, so if any symptoms of depression or mood changes occur during treatment, you should immediately inform your healthcare provider. Patients who are allergic to any of the ingredients in this medication should not take it. Moreover, patients with genetically-based lactose intolerance should also avoid taking this medication. Diabetic patients may need to adjust the dosage of their blood sugar control medications due to weight gain. If symptoms of angioedema appear, the medication should be stopped immediately. Elderly patients should be cautious of the risk of falls due to dizziness or drowsiness, and they may experience vision changes such as blurred vision. If this medication is suddenly discontinued, withdrawal symptoms such as insomnia, headache, nausea, and anxiety may occur, so consultation with healthcare providers is recommended when stopping the medication. Due to the risk of drug abuse, patients with a history of drug abuse should take extra caution. Patients with impaired renal function may need to adjust the dosage of this medication. Patients with heart disease should use it cautiously, as there is an increased risk of central nervous system depression when taken with opioid analgesics. Patients with compromised respiratory function or elderly patients may be at risk for severe respiratory depression and should consult with their healthcare provider. In early pregnancy, there is a risk of congenital malformations in the fetus, so women who are pregnant or planning to become pregnant should discuss with their doctor before taking this medication. Lactating women should consider stopping breastfeeding or discontinuing the medication, as it may pass into breast milk. This medication can cause dizziness and drowsiness, so activities such as driving or operating dangerous machinery should be avoided after taking it. In case of overdose, symptoms such as confusion, drowsiness, depression may occur, and treatment such as hemodialysis may be necessary. Store this medication out of reach of children, and it is recommended not to transfer it to another container. If any unusual symptoms such as skin rash, fever, or facial swelling occur during treatment, the medication should be stopped immediately and the healthcare provider informed.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, mucosal pain of mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by coughing and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, lightning headache, seizures, confusion of consciousness, vision disturbances, paralysis, urinary retention.

Mild side effects

• Dizziness
• drowsiness
• confusion
• spatial disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• derealization

This medication should be stored in a tightly sealed container to prevent air or moisture ingress. It is advisable to keep it in a cool place between 15 to 30 degrees Celsius.

Appearance

A hard capsule with a light brown upper part and a white lower part, containing a white or light yellow powder.

Package unit

30 capsules/bottle, 100 capsules/bottle